Skip to main content
Clinical Trials/CTRI/2019/07/020248
CTRI/2019/07/020248
Recruiting
未知

A Randomized controlled trial to study the efficacy and safety of plasma exchange compared to standard medical therapy in patients with severe drug induced liver injury with or without underlying chronic liver disease.

Institute of Liver and Biliary Sciences0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K746- Other and unspecified cirrhosis ofliver
Sponsor
Institute of Liver and Biliary Sciences
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Grade IV DILI With T.B \> 15
  • 2\) DILI Manifesting as ACLF (Acute on chronic Liver failure) /ALF (Acute Liver Failure) with no transplant option

Exclusion Criteria

  • 1\) Evidence of active infection
  • 2\) Refusal of consent or assent
  • 3\) Patients with clinical suspicion of irreversible brain injury
  • 4\) Pregnancy
  • 5\) HCC (Hepatocellular Carcinoma) or any other malignancy
  • 6\) Kidney failure
  • 7\) Portal vein thrombosis
  • 8\) Upper GastroIntestinal bleed
  • 9\) Transplant

Outcomes

Primary Outcomes

Not specified

Similar Trials